Patents by Inventor Philip Alexander MacFaul

Philip Alexander MacFaul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL DEPOT FOR N-{5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL)-3-FLUORO-4-(PYRIDIN-2-YLMETHOXY)BENZAMIDE
    Publication number: 20170135996
    Abstract: A pharmaceutical depot comprising (i) N-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide, or a pharmaceutically-acceptable salt thereof, as a pharmaceutical agent (PA) and (ii) a polymer which degrades to create an acidic microclimate, wherein the PA is released from the polymer upon polymer degradation.
    Type: Application
    Filed: January 30, 2017
    Publication date: May 18, 2017
    Inventors: Nicola Frances BATEMAN, Philip Alexander MACFAUL, Ian Alun NASH
  • PHARMACEUTICAL DEPOT FOR N-{5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL)-3-FLUORO-4-(PYRIDIN-2-YLMETHOXY)BENZAMIDE
    Publication number: 20160030400
    Abstract: A pharmaceutical depot comprising (i) N-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide, or a pharmaceutically-acceptable salt thereof, as a pharmaceutical agent (PA) and (ii) a polymer which degrades to create an acidic microclimate, wherein the PA is released from the polymer upon polymer degradation.
    Type: Application
    Filed: October 12, 2015
    Publication date: February 4, 2016
    Inventors: Nicola Frances BATEMAN, Philip Alexander MACFAUL, Ian Alun NASH
  • PHARMACEUTICAL DEPOT FOR 5-FLUORO-2-[[(1S)-1-(5-FLUORO-2-PYRIDYL)ETHYL]AMINO]-6-[(5-ISOPROPOXY-1H-PYRAZOL-3-YL)AMINO]PYRIDINE-3-CARBONITRILE
    Publication number: 20140045895
    Abstract: A pharmaceutical depot comprising (i) 5-fluoro-2-[[(1S)-1-(5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1H-pyrazol-3-yl)amino]pyridine-3-carbonitrile, or a pharmaceutically-acceptable salt thereof, as a pharmaceutical agent (PA) and (ii) a polymer which degrades to create an acidic microclimate, wherein the PA is released from the polymer upon polymer degradation.
    Type: Application
    Filed: September 12, 2013
    Publication date: February 13, 2014
    Applicant: ASTRAZENECA AB
    Inventors: Armelle Marie-Laudine JANIN, Philip Alexander Macfaul, Rachel Marie Pugh, Emily Jane Roberts, Ian Alun Nash
  • PHARMACEUTICAL DEPOT FOR N-{5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL)-3-FLUORO-4-(PYRIDIN-2-YLMETHOXY)BENZAMIDE
    Publication number: 20120149739
    Abstract: A pharmaceutical depot comprising (i) N-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide, or a pharmaceutically-acceptable salt thereof, as a pharmaceutical agent (PA) and (ii) a polymer which degrades to create an acidic microclimate, wherein the PA is released from the polymer upon polymer degradation.
    Type: Application
    Filed: February 21, 2012
    Publication date: June 14, 2012
    Applicant: AstraZeneca AB
    Inventors: Nicola Frances Bateman, Philip Alexander Macfaul, Ian Alun Nash
  • PHARMACEUTICAL DEPOT FOR N-{5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL)-3-FLUORO-4-(PYRIDIN-2-YLMETHOXY)BENZAMIDE
    Publication number: 20120149740
    Abstract: A pharmaceutical depot comprising (i) N-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide, or a pharmaceutically-acceptable salt thereof, as a pharmaceutical agent (PA) and (ii) a polymer which degrades to create an acidic microclimate, wherein the PA is released from the polymer upon polymer degradation.
    Type: Application
    Filed: February 21, 2012
    Publication date: June 14, 2012
    Applicant: AstraZeneca AB
    Inventors: Nicola Frances BATEMAN, Philip Alexander MACFAUL, Ian Alun NASH
  • PHARMACEUTICAL DEPOT FOR 5-FLUORO-2-[[(1S)-1-(5-FLUORO-2-PYRIDYL)ETHYL]AMINO]-6-[(5-ISOPROPOXY-1H-PYRAZOL-3-YL)AMINO]PYRIDINE-3-CARBONITRILE
    Publication number: 20120022110
    Abstract: A pharmaceutical depot comprising (i) 5-fluoro-2-[[(1S)-1-(5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1H-pyrazol-3-yl)amino]pyridine-3-carbonitrile, or a pharmaceutically-acceptable salt thereof, as a pharmaceutical agent (PA) and (ii) a polymer which degrades to create an acidic microclimate, wherein the PA is released from the polymer upon polymer degradation.
    Type: Application
    Filed: July 19, 2011
    Publication date: January 26, 2012
    Applicant: ASTRAZENECA AB
    Inventors: Armelle Marie-Laudine JANIN, Philip Alexander MACFAUL, Rachel Marie PUGH, Emily Jane ROBERTS, Ian Alun NASH
  • Therapeutic Agents 812
    Publication number: 20110065706
    Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as GPR119 modulators, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, and pharmaceutical compositions containing them.
    Type: Application
    Filed: September 10, 2010
    Publication date: March 17, 2011
    Applicant: AstraZeneca AB
    Inventors: Alan Martin Birch, Roger John Butlin, David Stephen Clarke, Andrew Leach, Philip Alexander MacFaul, Charles John O'Donnell, James Stewart Scott, Paul Robert Owen Whittamore, Dan Anders Broo, Öjvind Percy Davidsson, Kjell Erik Johansson, Hanna De La Motte
  • Compound 249
    Publication number: 20090281150
    Abstract: A pharmaceutical depot comprising (i) N-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide, or a pharmaceutically-acceptable salt thereof, as a pharmaceutical agent (PA) and (ii) a polymer which degrades to create an acidic microclimate, wherein the PA is released from the polymer upon polymer degradation.
    Type: Application
    Filed: April 8, 2009
    Publication date: November 12, 2009
    Inventors: Nicola Frances Bateman, Philip Alexander MacFaul, Ian Alun Nash